Drug Information

Drug General Information
Drug ID
D0X8HB
Former ID
DIB004556
Drug Name
NAV5001
Indication Dementia [ICD9: 290-294; ICD10:F01-F07] Phase 3 [524446]
Company
Navidea biopharmaceuticals
Target and Pathway
Target(s) Sodium-dependent dopamine transporter Target Info Modulator [534626]
KEGG Pathway Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholism
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathway
Pathway Interaction Database Alpha-synuclein signaling
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic Cleft
References
Ref 524446ClinicalTrials.gov (NCT01950455) Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes. U.S. National Institutes of Health.
Ref 534626Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse. 1998 Jun;29(2):128-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.